TFF Pharmaceuticals ( NASDAQ:TFFP – Get Rating ) had its price objective reduced by HC Wainwright from $22.00 to $4.00 in a research note issued to investors on Thursday, The Fly reports. Separately, Jonestrading initiated coverage on shares of TFF Pharmaceuticals in a research report on Wednesday, March 22nd. They issued a buy rating and a $7.00 price target on the stock. Shares of NASDAQ TFFP opened at $0.50 on Thursday. TFF Pharmaceuticals has a 52-week low of $0.48 and a 52-week high of $6.

https://www.dailypolitical.com/2023/05/29/tff-pharmaceuticals-nasdaqtffp-pt-lowered-to-4-00-at-hc-wainwright.html

#dailypolitical